Reduction in coronary artery bypass grafting surgery mortality and morbidity during a 3-year multicenter quality

Neil Worrall1, James Brevig2, Ruyun Jin3

  • 1Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Wash; Providence St Joseph Heart Institute, Renton, Wash.

Insights

A quality improvement initiative significantly reduced operative mortality for coronary artery bypass grafting by 50%. This surgeon-led effort involved data sharing and standardized processes, improving patient outcomes across 14 hospitals.

Area of Science:

  • Cardiovascular Surgery
  • Quality Improvement Science
  • Health Services Research

Background:

  • Operative mortality is a critical quality metric for isolated coronary artery bypass grafting (CABG).
  • A large, geographically dispersed healthcare system aimed to enhance CABG quality across its surgical programs.

Purpose of the Study:

  • To implement and evaluate a multicenter quality improvement initiative focused on reducing risk-adjusted operative mortality for isolated CABG.
  • To assess the impact of the initiative on mortality and morbidity rates.

Main Methods:

  • A multifaceted, surgeon-led quality improvement intervention was implemented across 14 surgical programs.
  • Data on observed and expected mortality/morbidity were collected from January 2014 to June 2017, using Society of Thoracic Surgeons risk models.
  • Key interventions included regular data sharing, standardized processes, quality improvement meetings, and care standardization through checklists.

Main Results:

  • The observed/expected mortality ratio decreased significantly from 1.19 (baseline) to 0.59 (outcome period), representing a 50% reduction (P = .004).
  • No significant changes were observed in expected mortality or case volume.
  • Observed/expected mortality/morbidity ratios also decreased, with near elimination of mortality without antecedent morbidity.

Conclusions:

  • A multifaceted quality improvement initiative achieved a significant and clinically meaningful 50% reduction in isolated CABG operative mortality.
  • Surgeon leadership, transparent data sharing, standardized processes, and a focus on care delivery were crucial for success.
  • The initiative also led to decreased morbidity, underscoring the effectiveness of a systematic approach to improving surgical quality.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
922
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
391
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
223
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
345
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
609
Fischer Projections02:18

Fischer Projections

Learning to draw Fischer projections of molecules and understanding their relevance plays a crucial role in the visual depiction of organic molecules. A Fischer projection is a two-dimensional projection on a planar surface to simplify the three-dimensional wedge–dash representation of molecules. This is especially helpful in the case of molecules with multiple chiral centers that can be difficult to draw. Here, all the bonds of interest are represented as horizontal or vertical lines. While...
16.4K